Lung Cancer Biomarker Testing ECHO 2022-2023 Expansion
September 2022 - May 2023
Building off the three-state pilot from 2021, this ECHO program will include Florida, South Carolina, Virginia, Texas, Louisiana, Arkansas, West Virginia, and Tennessee. The goals are for participants to gain knowledge and confidence to address the overlapping and common barriers that exist within their respective cancer teams and institutions and be equipped to successfully implement NSCLC biomarker testing in a multidisciplinary setting at their respective institutions.